Published in Biochim Biophys Acta on August 03, 1995
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev (2008) 3.51
Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A (1997) 2.25
Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci U S A (2000) 1.89
Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci U S A (2003) 1.76
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol (2005) 1.76
The endocannabinoid system in brain reward processes. Br J Pharmacol (2008) 1.71
Chemical probes of endocannabinoid metabolism. Pharmacol Rev (2013) 1.68
Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol (2003) 1.66
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J (1997) 1.57
Structural determinants for recognition and translocation by the anandamide transporter. Proc Natl Acad Sci U S A (1999) 1.51
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology (2009) 1.47
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol (2007) 1.34
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discov (2009) 1.22
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem (2008) 1.18
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry (2012) 1.14
A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. J Neurosci (2008) 1.13
A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo. ChemMedChem (2009) 1.11
More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology (2013) 1.10
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Br J Pharmacol (2004) 1.10
Expression and function of fatty acid amide hydrolase in prostate cancer. Int J Cancer (2008) 1.09
The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology (2008) 1.07
Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus (2010) 1.03
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. Recent Pat CNS Drug Discov (2012) 0.91
Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. J Mol Neurosci (2007) 0.91
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. Br J Pharmacol (2001) 0.90
Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience (2011) 0.88
Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase. Br J Pharmacol (2000) 0.86
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) (2006) 0.86
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.86
Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc Psychiatry Ment Health (2008) 0.86
Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br J Pharmacol (2002) 0.86
The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci (2012) 0.85
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology (Berl) (2007) 0.85
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. CNS Neurol Disord Drug Targets (2008) 0.85
Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse (2012) 0.85
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection. Mol Brain (2016) 0.84
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability. Eur J Med Chem (2011) 0.82
Developmental regulation of fear learning and anxiety behavior by endocannabinoids. Genes Brain Behav (2015) 0.82
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins Other Lipid Mediat (2009) 0.81
Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des (2014) 0.80
Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity. BMC Med Genet (2010) 0.80
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. Psychoneuroendocrinology (2016) 0.80
Endocannabinoids in the dentate gyrus. Prog Brain Res (2007) 0.79
Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([(11)C]MPPO) Based on α-Ketoheterocyclic Scaffold. ACS Chem Neurosci (2015) 0.78
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. Neuropsychopharmacology (2017) 0.78
O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors. ChemMedChem (2014) 0.78
Brain region-specific changes in N-acylethanolamine contents with time of day. J Neurochem (2013) 0.78
Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity. J Biol Chem (2014) 0.77
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. Brain Behav Immun (2016) 0.76
A chemical genetic screen uncovers a small molecule enhancer of the N-acylethanolamine degrading enzyme, fatty acid amide hydrolase, in Arabidopsis. Sci Rep (2017) 0.75
Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years. Front Mol Neurosci (2017) 0.75
Pre-arrest morbidity and other correlates of survival after in-hospital cardiopulmonary arrest. Am J Med (1989) 3.66
Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res (2000) 2.67
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol (1999) 2.12
Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med (1981) 2.00
Anomalous origin of the left circumflex coronary artery. Recognition, antiographic demonstration and clinical significance. Circulation (1974) 1.97
Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins. Br J Surg (2006) 1.87
Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res (1995) 1.76
Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res (1999) 1.75
Lower limb amputation: striking the balance. Ann R Coll Surg Engl (1994) 1.74
Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem (1997) 1.68
Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther (1999) 1.67
The pharmacologic alteration of renin release. Pharmacol Rev (1980) 1.65
The management of short saphenous varicose veins: a survey of the members of the vascular surgical society of Great Britain and Ireland. Eur J Vasc Endovasc Surg (2004) 1.63
Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol (1994) 1.57
Quality of life following surgery for abdominal aortic aneurysm. Br J Surg (1992) 1.55
Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res (1997) 1.53
The mortality of abdominal aortic aneurysm. Ann R Coll Surg Engl (1986) 1.50
Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol (1993) 1.49
Endoscopic transanal resection of rectal tumours--a preliminary report of its use. Br J Surg (1990) 1.47
Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem (2001) 1.45
Intraoperative heparinisation, blood loss and myocardial infarction during aortic aneurysm surgery: a Joint Vascular Research Group study. Eur J Vasc Endovasc Surg (1996) 1.40
Auditing the vascular surgical audit. Br J Surg (1987) 1.39
Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta (1996) 1.38
What is the place of surgery for intermittent claudication? Eur J Vasc Endovasc Surg (2010) 1.38
Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation (1986) 1.35
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol (1998) 1.34
Cost-effectiveness analysis of surgery versus conservative treatment for uncomplicated varicose veins in a randomized clinical trial. Br J Surg (2006) 1.32
Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat. Circ Res (1973) 1.27
Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am J Physiol (1991) 1.26
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation (1989) 1.21
Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res (2001) 1.20
Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells. Prostaglandins (1982) 1.20
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. J Neurochem (2000) 1.17
Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci (1994) 1.17
Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol (1990) 1.16
Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J Neurochem (1995) 1.16
Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br J Pharmacol (1996) 1.15
Prophylaxis of infection after appendicectomy: a survey of current surgical practice. Br Med J (1980) 1.14
Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem (2001) 1.13
The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic neurotransmission. Eur J Pharmacol (1980) 1.12
Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. Kidney Int (1985) 1.10
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol (1998) 1.09
Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial. Br J Surg (1984) 1.08
Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res (1998) 1.08
Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. Circulation (1987) 1.08
Peritonitis causing acute limb ischaemia. Eur J Vasc Surg (1992) 1.08
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Circ Res (1986) 1.07
The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. Circ Res (1984) 1.05
Management of major colonic haemorrhage. Br J Surg (1988) 1.05
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation (1989) 1.04
Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation (1984) 1.04
Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res (1990) 1.03
Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol (2001) 1.03
Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess (2006) 1.02
Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: serial CK-MB sampling in the emergency department. Ann Emerg Med (1990) 1.02
11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. Circ Res (1999) 1.02
Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem (1998) 1.00
Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest (1979) 1.00
Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet (1982) 1.00
Cortical and papillary micropuncture examination of chloride transport in segments of the rat kidney during inhibition of prostaglandin production. Possible role for prostaglandins in the chloruresis of acute volume expansion. J Clin Invest (1979) 0.99
Heart rates in freely diving Weddell Seals, Leptonychotes weddelli. Comp Biochem Physiol A Comp Physiol (1972) 0.98
Sodium chloride suppression of renin release in the unanesthetized rat. Endocrinology (1975) 0.97
Should we palpate foot pulses? Ann R Coll Surg Engl (1992) 0.97
Ruptured aortic aneurysm: the decision not to operate. Ann R Coll Surg Engl (1998) 0.97
Measurement of prostaglandins by radioimmunoassay. Methods Enzymol (1987) 0.96
Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circ Res (1985) 0.96
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. Am J Cardiol (1984) 0.96
A new and safe system for oesophageal dilatation. Lancet (1981) 0.96
Coronary artery disease in young women. JAMA (1974) 0.95
Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. J Pharmacol Exp Ther (1998) 0.95
Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol (2001) 0.94
Evidence for a renal alpha-adrenergic receptor inhibiting renin release. Circ Res (1976) 0.94
20-HETE relaxes bovine coronary arteries through the release of prostacyclin. Hypertension (1998) 0.94
A comparative study of treadmill tests and heel raising exercise for peripheral arterial disease. Eur J Vasc Endovasc Surg (1997) 0.94
Use of coughing test to diagnose peritonitis. BMJ (1994) 0.94
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. J Lipid Res (1997) 0.94
Angiotensin II- and angiotensin 3-induced aldosterone release vivo in the rat. Science (1974) 0.93
Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries. Hypertension (2000) 0.93
cADP-ribose activates reconstituted ryanodine receptors from coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol (2001) 0.93
Colonoscopy following intraoperative lavage in the management of severe colonic bleeding. Ann R Coll Surg Engl (1985) 0.93
Nitric oxide inhibits Ca(2+) mobilization through cADP-ribose signaling in coronary arterial smooth muscle cells. Am J Physiol Heart Circ Physiol (2000) 0.92
Vasorelaxation by an endothelium-derived metabolite of arachidonic acid. Am J Physiol (1996) 0.92
Renin release, an artifact of anesthesia and its implications in rats. Proc Soc Exp Biol Med (1975) 0.92
Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators. Hypertension (1997) 0.91
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med (1988) 0.91
Characterization of normal and malignant human hepatocytes by Raman microspectroscopy. Cancer Lett (1996) 0.91
Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. J Am Coll Cardiol (1984) 0.90
Endothelial cell nitric oxide inhibits aldosterone synthesis in zona glomerulosa cells: modulation by oxygen. Am J Physiol Endocrinol Metab (2000) 0.90
A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins. Hypertension (1981) 0.90
Cystic adventitial disease of the common femoral artery communicating with the hip joint. Br J Surg (1985) 0.90
Endothelium-dependent contractions in rabbit pulmonary artery are mediated by thromboxane A2. Circ Res (1993) 0.90
Outpatient clinic review after arterial reconstruction: is it necessary? Ann R Coll Surg Engl (1994) 0.90
Organ specificity of angiotensin II and Des-aspartyl angiotensin II in the conscious rat. J Pharmacol Exp Ther (1976) 0.89